DRUG STUDY
Glenmark drug Oglemilast fails in key studyGlenmark-Pharma[1].jpg19 Aug, 2009, 01.22 PM IST
India's drug regulator okays study on mixing Covaxin and Covishield11 Aug, 2021, 03.40 PM IST
Covid-19: SEC nod for Bharat Biotech to conduct Phase III booster dose study for its intranasal vaccine05 Jan, 2022, 11.50 AM IST
- Load More